Skip to search formSkip to main contentSkip to account menu

LY 2140023

Known as: LY-2140023, LY2140023 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Significance: LY2140023 is a conformationally restricted glutamic acid analogue that is an mGlu2/3 receptor agonist. It entered… 
2010
2010
The present invention relates to methods of treating schizophrenia with Group II mGlu receptor agonists wherein genetic variants…